Wall Street Pummels NeuroBo Pharmaceuticals Inc. (NRBO) After Recent Earnings Report

NeuroBo Pharmaceuticals Inc. (NASDAQ:NRBO) went up by 20.28% from its latest closing price compared to the recent 1-year high of $63.85. The company’s stock price has collected -10.99% of loss in the last five trading sessions.

Is It Worth Investing in NeuroBo Pharmaceuticals Inc. (NASDAQ :NRBO) Right Now?

Plus, the 36-month beta value for NRBO is at 0.12.

NRBO currently public float of 0.42M and currently shorts hold a 11.65% ratio of that float. Today, the average trading volume of NRBO was 549.50K shares.

NRBO’s Market Performance

NRBO stocks went down by -10.99% for the week, with a monthly drop of -26.87% and a quarterly performance of -22.84%, while its annual performance rate touched -81.94%. The volatility ratio for the week stands at 14.66% while the volatility levels for the past 30 days are set at 13.11% for NeuroBo Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is -16.79% for NRBO stocks with a simple moving average of -48.47% for the last 200 days.

Analysts’ Opinion of NRBO

Many brokerage firms have already submitted their reports for NRBO stocks, with H.C. Wainwright repeating the rating for NRBO by listing it as a “Buy.” The predicted price for NRBO in the upcoming period, according to H.C. Wainwright is $20 based on the research report published on June 15th of the previous year 2020.

NRBO Trading at -24.91% from the 50-Day Moving Average

After a stumble in the market that brought NRBO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.72% of loss for the given period.

Volatility was left at 13.11%, however, over the last 30 days, the volatility rate increased by 14.66%, as shares sank -22.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.77% lower at present.

During the last 5 trading sessions, NRBO fell by -10.99%, which changed the moving average for the period of 200-days by -76.27% in comparison to the 20-day moving average, which settled at $11.59. In addition, NeuroBo Pharmaceuticals Inc. saw -73.35% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for NRBO

Equity return is now at value -137.10, with -117.40 for asset returns.

Leave a Reply

Your email address will not be published. Required fields are marked *